The Maintrac Customised Chemosensitivity Testing
Some Circulating Tumour Cells (CTCs) can hide in the blood stream for months or years before activating and forming a second tumour. Some CTCs may even resist treatment. This test analyses how a person’s CTCs respond when exposed to a recommended chemotherapy regimen or botanical treatment. CTCs that die or survive exposure are said to be ‘sensitive’ or ‘resistant’ to the tested treatment, respectively.
Recommended therapies can now be tested. Each test is customised specifically for each patient by the requesting practitioner.
Maintrac’s Customised Chemosensitivity test can be used to:
- Analyse if a person’s CTCs are sensitive or resistant to a recommended treatment
- Assist practitioners in deciding on a treatment plan
- Increase confidence in the therapy’s ability to reduce cancer spread effectively
This test can only be ordered in addition to a CTC Count.
Maintrac® is a state-of-the-art German technology that detects, characterises and tests CTCs. It has been critically validated and published in peer reviewed journals for over 12 years. Maintrac® CTC tests are acknowledged and utilised by many universities, Oncologists and cancer clinics worldwide. Maintrac has obtained the highest level accreditation possible for medical testing.
“The best way to monitor cancer activity and long-term effectiveness of treatment is via a single CTC count test every 3-6 months.”